Day and colleagues demonstrated that MK-8776 synergistically potentiated the histone deacetylase (HDAC) inhibitor (HDACI) vorinostat in both AML cell lines and primary cells [92]. The gene discussed is HDAC9; the disease is acute myeloid leukemia.